2006
DOI: 10.1111/j.1469-7610.2006.01588.x
|View full text |Cite
|
Sign up to set email alerts
|

Practitioner Review: Psychopharmacology in children and adolescents with mental retardation

Abstract: The use of psychotropic medications in children and adolescents with MR requires even greater monitoring and the use of lower doses and slower dosage increases than in the general population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
52
0
8

Year Published

2010
2010
2012
2012

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 82 publications
(60 citation statements)
references
References 74 publications
(131 reference statements)
0
52
0
8
Order By: Relevance
“…The prevalence rate of ADHD in the general population is 5%, (18) and between 9% to 16% in the paediatric population with an ID (19). The long-term impact of ADHD is significant in children with an ID, and can result in anxiety, aggression and social ostracism problems, especially in adolescents (20).…”
Section: Intellectual Disability and Adhdmentioning
confidence: 99%
See 4 more Smart Citations
“…The prevalence rate of ADHD in the general population is 5%, (18) and between 9% to 16% in the paediatric population with an ID (19). The long-term impact of ADHD is significant in children with an ID, and can result in anxiety, aggression and social ostracism problems, especially in adolescents (20).…”
Section: Intellectual Disability and Adhdmentioning
confidence: 99%
“…Response rates vary between 45% to 66% in the population with an ID, versus 77% in the population without an ID (19), with benefits including decreased impulsivity, inattention and hyperactivity, in both classroom and leisure activities.…”
Section: Pharmacological Treatmentmentioning
confidence: 99%
See 3 more Smart Citations